Pharmacokinetic Similarity of ABP 710, a Proposed Biosimilar to Infliximab: Results From a Randomized, Single‐Blind, Single‐Dose, Parallel‐Group Study in Healthy Subjects

Por Chow, Vincent, Oh, MyungShin, Gessner, Melissa A., Fanjiang, Gary
Publicado no Clin Pharmacol Drug Dev (2019)

Global Expression-Based Classification of Lymph Node Metastasis and Extracapsular Spread of Oral Tongue Squamous Cell Carcinoma

Por Zhou, Xiaofeng, Temam, Stephane, Oh, Myungshin, Pungpravat, Nisa, Huang, Bau-Lin, Mao, Li, Wong, David T
Publicado em 2006

A female preponderance for chemically induced lupus in SJL/J mice

Por Smith, Deborah L., Dong, Xin, Du, Sienmi, Oh, MyungShin, Singh, Ram Raj, Voskuhl, Rhonda R.
Publicado em 2006

Comparative clinical efficacy and safety of the proposed biosimilar ABP 710 with infliximab reference product in patients with rheumatoid arthritis

Por Genovese, Mark C., Sanchez-Burson, Juan, Oh, MyungShin, Balazs, Eva, Neal, Jeffrey, Everding, Andrea, Hala, Tomas, Wojciechowski, Rafal, Fanjiang, Gary, Cohen, Stanley
Publicado no Arthritis Res Ther (2020)

Differences in Presentation of Younger and Older Systemic Sclerosis Patients in Clinical Trials

Por Weng, Haoling H, Ranganath, Veena K, Oh, Myungshin, Park, Grace S, Khanna, Dinesh, Clements, Philip J, Seibold, James R, Elashoff, David A, Furst, Daniel E
Publicado em 2010

Equivalent Responses to DMARDs Initiated at Any Time During the First 15 Months After Symptom Onset in Seropositive RA Patients: An Observational Study

Por Weng, Haoling H., Ranganath, Veena K., Khanna, Dinesh, Oh, Myungshin, Furst, Daniel E., Park, Grace S., Elashoff, David A., Sharp, John T., Gold, Richard H., Peter, James B., Paulus, Harold E.
Publicado em 2010